FRAGILE X SYNDROME (FXS)
Clinical trials for FRAGILE X SYNDROME (FXS) explained in plain language.
Never miss a new study
Get alerted when new FRAGILE X SYNDROME (FXS) trials appear
Sign up with your email to follow new studies for FRAGILE X SYNDROME (FXS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug SPG601 aims to boost brain function in fragile x patients
Symptom relief Not yet recruitingThis study tests a new drug called SPG601 in adult men with Fragile X syndrome. The goal is to see if it can improve thinking and brain function. About 248 participants will receive either the drug or a placebo. The study is not yet recruiting.
Matched conditions: FRAGILE X SYNDROME (FXS)
Phase: PHASE2, PHASE3 • Sponsor: Spinogenix • Aim: Symptom relief
Last updated Jun 27, 2026 09:08 UTC
-
Scientists to unravel trust in intellectual disability
Knowledge-focused Not yet recruitingThis study looks at how people with Down syndrome and Fragile X syndrome decide who to trust. Researchers will use eye-tracking and behavioral tasks to measure how participants read faces, behaviors, and detect deception. The goal is to understand the brain mechanisms behind trus…
Matched conditions: FRAGILE X SYNDROME (FXS)
Sponsor: Hospices Civils de Lyon • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:08 UTC